Acrivon Therapeutics Overview
Acrivon Therapeutics Target Price
Analysts' 12-month price predictions for ACRV.
Get informed when a big investor buys or sells
+ FollowShare Price
$1.48
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-11-14 | BMO CapitalEtzer Darout | $27 |  1724.3% upside |  |
| 2024-09-16 | BMO CapitalEtzer Darout | $28 | 1791.9% upside | |
| 2024-08-13 | OppenheimerMatthew Biegler | $18 | 1116.2% upside | |
| 2024-05-14 | OppenheimerMatthew Biegler | $21 | 1318.9% upside | |
| 2024-05-14 | H.C. WainwrightEmily Bodnar | $22 | 1386.5% upside | |
| 2024-05-14 | BMO CapitalEtzer Darout | $25 | 1589.2% upside | |
| 2024-04-25 | Piper SandlerJoseph Catanzaro | $30 | 1927% upside | |
| 2024-04-25 | JMP SecuritiesSilvan Tuerkcan | $17 | 1048.6% upside | |
| 2024-03-28 | H.C. WainwrightEmily Bodnar | $20 | 1251.4% upside | |
| 2022-12-12 | Jefferies | $17 | 1048.6% upside | |
| 2022-12-11 | Piper SandlerJoseph Catanzaro | $25 | 1589.2% upside | |